ArticleCurrent oncology (Toronto, Ont.)2025

Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting.

Ibraheem Othman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.